Global /India /Healthcare /Drug Manufacturers - General /531569

Sanjivani Paranteral Ltd.

531569 (SANJIVIN)

• BSE: 531569 • Delayed

160.00INR -2%

1.69 USD

As of 21 June 2026, Sanjivani Paranteral Ltd. has a market cap of $20.82M USD, ranking #36821 globally and #2627 in India. It ranks #3313 in the Healthcare sector, and #1108 in the Drug Manufacturers - General industry.

Global Rank

36821

Country Rank

2627

Sector Rank

3313

Industry Rank

1108

Key Stats

Market Cap

$20.82MUSD

1.97B INR

Enterprise Value

$21.99MUSD

2.08B INR

Revenue (TTM)

$7.8MUSD

736.34M INR

EBITDA (TTM)

$1.16MUSD

109.87M INR

Net Income (TTM)

$876.25KUSD

82.71M INR

EBITDA Margin

15%

Profit Margin

11%

PE Ratio

24.2

PS Ratio

2.7

PB Ratio

4.2

EV/EBITDA

18.9

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ashwani Khemka open_in_new

Employees

Founded

1994

Website

sanjivani.co.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2%	-4.8%	14%	-11%	-22%	-31%	-33%	183%	1K%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	531569 (SANJIVIN) Sanjivani Paranterals Ltd ISIN: INE860D01013 Shares Out.: Shares Outstanding: 12.284M¹ Shares Float: 8.659M² TV: TradingView: BSE: SANJIVIN SA: Stock Analysis: BOM: 531569 YF: Yahoo Finance: 531569.BO GF: Google Finance: BOM: 531569 BA: Barron's: 531569 MS: Morningstar: XBOM: 531569	160.00 INR	TV: TradingView: BSE: SANJIVIN SA: Stock Analysis: BOM: 531569 YF: Yahoo Finance: 531569.BO GF: Google Finance: BOM: 531569 BA: Barron's: 531569 MS: Morningstar: XBOM: 531569

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Sanjivani Paranteral Ltd.

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops. In addition, the company exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 217K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 88K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 73K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 56K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 47K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 47K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 4M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 3M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 2M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 2M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 1M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 1M%	15.1	United States

chevron_leftBack